|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/22 | |
| A61K 31/198 | |||
| A61K 45/06 | |||
| C07C 229/00 |
| (11) | Number of the document | 2234963 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08866933.8 |
| Date of filing the European patent application | 2008-12-26 | |
| (97) | Date of publication of the European application | 2010-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/014080 |
| Date | 2008-12-26 |
| (87) | Number | WO 2009/085306 |
| Date | 2009-07-09 |
| (30) | Number | Date | Country code |
| 9457 | 2007-12-28 | US |
| (72) |
HSU, Ann, US
KOU, Jim, H., US
ALANI, Laman, Lynn, US
|
| (73) |
Impax Laboratories, LLC,
30831 Huntwood Avenue, Hayward, CA 94544,
US
|
| (54) | CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF |
| CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF |